How about something meaningful instead of your endless, completely meaningless comparisons?And talking about EPP dominance at cuv is probably a joke. 500 patients corresponds to a penetration of at most 10%. If Wolgen were a good negotiator and not an egocentric, Clinuvel could actually have outstanding and influential market power in this area. He had more than a decade to do it. A missed opportunity that won't come back.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$9.83 |
Change
-0.350(3.44%) |
Mkt cap ! $492.7M | |||
| Open | High | Low | Value | Volume |
| $10.18 | $10.18 | $9.75 | $1.391M | 140.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9965 | $9.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.89 | 370 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| CUV (ASX) Chart |